CVI Investments, Inc. 13D and 13G filings for Processa Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 2:01 pm Purchase | 2025-06-30 | 13G | Processa Pharmaceuticals, Inc. PCSA | CVI Investments, Inc. | 4,471,067 9.900% | 1,807,989 (+67.89%) | Filing |
| 2025-06-24 10:00 am Purchase | 2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA | CVI Investments, Inc. | 2,663,078 9.900% | 2,663,078 (New Position) | Filing |